Immucor

Immucor

Provider of transfusion and transplantation diagnostic products.

HQ location
Norcross, United States
Launch date
Enterprise value
$2.0b
Recent deals
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
*

$2.0b

Valuation: $2.0b

Acquisition
Total Funding000k
TPG
TPG(exited)
MBC Biolabs
MBC Biolabs(exited)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR20152016
Revenues00000000
EBITDA00000000
Profit00000000
EV00000000
EV / revenue00.0x00.0x
EV / EBITDA00.0x00.0x
R&D budget00000000

Source: Company filings or news article

Notes (0)
More about Immucor
Made with AI
Edit

Immucor is a prominent player in the transfusion and transplantation diagnostics market. The company specializes in providing diagnostic products that ensure the safe and accurate matching of blood and organs for patients in need. Immucor serves a diverse clientele, including hospitals, clinical laboratories, reference laboratories, and donor centers globally. The business model revolves around selling diagnostic kits and software solutions that streamline and automate the testing process, making it faster and more reliable. Revenue is generated through the sale of these products and ongoing support services. Immucor's commitment to innovation and quality has made it a trusted partner in the healthcare industry, dedicated to enhancing patient care and safety.

Keywords: transfusion, transplantation, diagnostics, blood matching, organ matching, hospitals, clinical laboratories, donor centers, automation, patient care.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Immucor

Edit
Organ-i
ACQUISITION by Immucor Jun 2014